Healthcare provider profile · identity verified

Zuylan Riera Vicente, MD

Internal Medicine · HIALEAH, FL · NPI 1629509526

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1800	347
Losartan Potassium	Losartan Potassium	794	189
Pantoprazole Sodium	Pantoprazole Sodium	671	148
Amlodipine Besylate	Amlodipine Besylate	606	125
Gabapentin	Gabapentin	592	112
Metformin Hcl	Metformin Hcl	552	104
Rosuvastatin Calcium	Rosuvastatin Calcium	551	100
Levothyroxine Sodium	Levothyroxine Sodium	538	98
Glipizide	Glipizide	449	71
Folic Acid	Folic Acid	426	65
Sildenafil Citrate	Sildenafil Citrate	387	64
Lisinopril	Lisinopril	386	100
Hydrochlorothiazide	Hydrochlorothiazide	382	85
Metoprolol Succinate	Metoprolol Succinate	360	86
Metoprolol Tartrate	Metoprolol Tartrate	342	69
Xarelto	Rivaroxaban	304	39
Furosemide	Furosemide	282	65
Vitamin D2	Ergocalciferol (Vitamin D2)	280	90
Tamsulosin Hcl	Tamsulosin Hcl	272	75
Temazepam	Temazepam	262	44
Memantine Hcl	Memantine Hcl	247	46
Albuterol Sulfate Hfa	Albuterol Sulfate	244	39
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	240	46
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	240	57
Unifine Pentips	Pen Needle, Diabetic	237	39
Ibandronate Sodium	Ibandronate Sodium	233	44
Pioglitazone Hcl	Pioglitazone Hcl	232	36
Trazodone Hcl	Trazodone Hcl	220	40
Nifedipine Er	Nifedipine	213	48
Famotidine	Famotidine	205	57
Carvedilol	Carvedilol	197	34
Clopidogrel	Clopidogrel Bisulfate	189	50
Alendronate Sodium	Alendronate Sodium	185	35
Montelukast Sodium	Montelukast Sodium	184	43
Simvastatin	Simvastatin	179	41
Oxybutynin Chloride Er	Oxybutynin Chloride	176	30
Escitalopram Oxalate	Escitalopram Oxalate	174	44
Omeprazole	Omeprazole	167	49
Mirtazapine	Mirtazapine	163	39
Donepezil Hcl	Donepezil Hcl	155	36
Methocarbamol	Methocarbamol	151	102
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	145	53
Labetalol Hcl	Labetalol Hcl	138	21
Latanoprost	Latanoprost	138	21
Lantus	Insulin Glargine,hum.Rec.Anlog	115	13
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	113	25
Glimepiride	Glimepiride	112	20
Sertraline Hcl	Sertraline Hcl	109	29
Finasteride	Finasteride	108	30
Meclizine Hcl	Meclizine Hcl	107	43
Alprazolam	Alprazolam	106	31
Esomeprazole Magnesium	Esomeprazole Magnesium	103	15
Quetiapine Fumarate	Quetiapine Fumarate	103	23
Duloxetine Hcl	Duloxetine Hcl	95	19
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	90	22
Clobetasol Propionate	Clobetasol Propionate	86	54
Eliquis	Apixaban	83	14
Hydralazine Hcl	Hydralazine Hcl	81	16
Azithromycin	Azithromycin	78	69
Levetiracetam	Levetiracetam	78	11
Spironolactone	Spironolactone	78	16
Benzonatate	Benzonatate	77	71
Glipizide Er	Glipizide	77	15
Entresto	Sacubitril/Valsartan	73	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	71	suppressed
Prednisone	Prednisone	71	38
Farxiga	Dapagliflozin Propanediol	70	16
Bumetanide	Bumetanide	69	11
Buspirone Hcl	Buspirone Hcl	68	14
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	66	13
Synthroid	Levothyroxine Sodium	63	suppressed
Nystatin	Nystatin	62	38
Ammonium Lactate	Ammonium Lactate	60	29
Diclofenac Sodium	Diclofenac Sodium	60	45
Pregabalin	Pregabalin	60	suppressed
Tradjenta	Linagliptin	60	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	16
Tramadol Hcl	Tramadol Hcl	56	24
Jardiance	Empagliflozin	49	suppressed
Ciclopirox	Ciclopirox	46	22
Ranolazine Er	Ranolazine	45	suppressed
Trueplus Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	43	suppressed
Enalapril Maleate	Enalapril Maleate	42	suppressed
Allopurinol	Allopurinol	41	12
Insulin Aspart	Insulin Aspart	41	suppressed
Fenofibrate	Fenofibrate	39	suppressed
Lactulose	Lactulose	39	20
Fluticasone Propionate	Fluticasone Propionate	38	30
Ezetimibe	Ezetimibe	36	suppressed
Procto-Med Hc	Hydrocortisone	36	21
Trueplus Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	36	suppressed
Insulin Aspart Flexpen	Insulin Aspart	35	11
Ventolin Hfa	Albuterol Sulfate	35	suppressed
Amiodarone Hcl	Amiodarone Hcl	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Triazolam	Triazolam	32	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Potassium Chloride	Potassium Chloride	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Methylprednisolone	Methylprednisolone	30	28
Atenolol	Atenolol	29	suppressed
Lansoprazole	Lansoprazole	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	28	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	24
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Tadalafil	Tadalafil	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	24
Ketoconazole	Ketoconazole	26	20
Lorazepam	Lorazepam	26	suppressed
Metronidazole	Metronidazole	26	22
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	23
Isosorbide Dinitrate	Isosorbide Dinitrate	23	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	23	suppressed
Trueplus Insulin Syringe	Syringe And Needle,insulin,1ml	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Lumigan	Bimatoprost	21	suppressed
Lubiprostone	Lubiprostone	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Ciclopirox	Ciclopirox Olamine	19	suppressed
Methotrexate	Methotrexate Sodium	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	11
Brilinta	Ticagrelor	18	suppressed
Cephalexin	Cephalexin	18	18
Irbesartan	Irbesartan	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	15
Captopril	Captopril	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	13
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	16	suppressed
Methimazole	Methimazole	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Anastrozole	Anastrozole	15	suppressed
Dutasteride	Dutasteride	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Ssd	Silver Sulfadiazine	15	12
Digoxin	Digoxin	14	suppressed
Mupirocin	Mupirocin	14	13
Valsartan	Valsartan	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Levofloxacin	Levofloxacin	13	11
Lokelma	Sodium Zirconium Cyclosilicate	13	suppressed
Meloxicam	Meloxicam	13	12
Naproxen	Naproxen	13	13
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Prevacid	Lansoprazole	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Baclofen	Baclofen	11	11
Diovan Hct	Valsartan/Hydrochlorothiazide	11	suppressed
Erythromycin	Erythromycin Base	11	11
Rytary	Carbidopa/Levodopa	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed
Xanax	Alprazolam	11	suppressed
Zocor	Simvastatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error